Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$370 Hold
117
﹤0.01% 317
2026
Q1
$345 Hold
117
﹤0.01% 310
2025
Q4
$308 Sell
117
-117
-50% -$279 ﹤0.01% 318
2025
Q3
$527 Hold
234
﹤0.01% 254
2025
Q2
$569 Hold
234
﹤0.01% 234
2025
Q1
$458 Hold
234
﹤0.01% 234
2024
Q4
$458 Hold
234
﹤0.01% 318
2024
Q3
$571 Hold
234
﹤0.01% 353
2024
Q2
$480 Hold
234
﹤0.01% 356
2024
Q1
$580 Hold
234
﹤0.01% 349
2023
Q4
$691 Buy
+234
New +$632 ﹤0.01% 338

Other funds holding ABEV

Fairman Group's ABEV Position: Q2 2026 in Review

Fairman Group held its Ambev (ABEV) position steady in Q2 2026 at 117 shares worth $370. The position accounts for ﹤0.01% of the portfolio, ranked #317.

Fairman Group first reported a position in ABEV in Q4 2023 and has held it in 11 quarters since. The position peaked at $691 in Q4 2023. 204 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Fairman Group held 117 shares of Ambev worth $370 as of Q2 2026.
  • Fairman Group left its Ambev share count unchanged in Q2 2026.
  • Ambev made up ﹤0.01% of Fairman Group's portfolio in Q2 2026, its #317 holding.
  • Fairman Group first reported a position in Ambev in Q4 2023 and has held it in 11 quarters since.
  • Fairman Group's Ambev position peaked at $691 in Q4 2023.
  • 204 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Fairman Group's 13F filing for Q2 2026, filed 4 Aug 2026.